Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 1998, p. 5445-5456, Vol. 18, No. 9
Biochemistry Department, University of
Missouri
Received 13 March 1998/Returned for modification 30 April
1998/Accepted 10 June 1998
The I
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Loss of I
B
-Mediated Control over Nuclear
Import and DNA Binding Enables Oncogenic Activation of c-Rel
Columbia, Columbia, Missouri 65212
B
protein is able both to inhibit nuclear import of
Rel/NF-
B proteins and to mediate the export of Rel/NF-
B proteins from the nucleus. We now demonstrate that the c-Rel-I
B
complex is stably retained in the cytoplasm in the presence of leptomycin B, a
specific inhibitor of Crm1-mediated nuclear export. In contrast, leptomycin B treatment results in the rapid and complete relocalization of the v-Rel-I
B
complex from the cytoplasm to the nucleus.
I
B
also mediates the rapid nuclear shuttling of v-Rel in an
interspecies heterokaryon assay. Thus, continuous nuclear export is
required for cytoplasmic retention of the v-Rel-I
B
complex.
Furthermore, although I
B
is able to mask the c-Rel-derived
nuclear localization sequence (NLS), I
B
is unable to mask the
v-Rel-derived NLS in the context of the v-Rel-I
B
complex. Taken
together, our results demonstrate that I
B
is unable to inhibit
nuclear import of v-Rel. We have identified two amino acid differences
between c-Rel and v-Rel (Y286S and L302P) which link the failure of
I
B
to inhibit nuclear import and DNA binding of a mutant c-Rel
protein to oncogenesis. Our results support a model in which loss of
I
B
-mediated control over c-Rel leads to oncogenic activation of
c-Rel.
*
Corresponding author. Mailing address:
Biochemistry Department, University of Missouri
Columbia, Columbia, MO
65212. Phone: (573) 882-7971. Fax: (573) 884-4597. E-mail:
hanninkm{at}missouri.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|